nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HTR2C—metabolic syndrome X	0.676	1	CbGaD
Asenapine—HTR7—sympathetic nervous system—metabolic syndrome X	0.00799	0.0907	CbGeAlD
Asenapine—HTR2A—arteriole—metabolic syndrome X	0.00782	0.0887	CbGeAlD
Asenapine—HTR7—autonomic nervous system—metabolic syndrome X	0.00537	0.061	CbGeAlD
Asenapine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00498	0.0565	CbGeAlD
Asenapine—HTR1B—artery—metabolic syndrome X	0.00395	0.0448	CbGeAlD
Asenapine—HTR1D—artery—metabolic syndrome X	0.00382	0.0434	CbGeAlD
Asenapine—HTR2A—autonomic nervous system—metabolic syndrome X	0.00335	0.038	CbGeAlD
Asenapine—Toothache—Metformin—metabolic syndrome X	0.0033	0.0857	CcSEcCtD
Asenapine—UGT1A4—kidney—metabolic syndrome X	0.00325	0.0369	CbGeAlD
Asenapine—HTR1B—blood vessel—metabolic syndrome X	0.00308	0.0349	CbGeAlD
Asenapine—Upset stomach—Metformin—metabolic syndrome X	0.00306	0.0796	CcSEcCtD
Asenapine—HTR7—artery—metabolic syndrome X	0.00305	0.0346	CbGeAlD
Asenapine—HTR1D—blood vessel—metabolic syndrome X	0.00298	0.0338	CbGeAlD
Asenapine—HTR7—endothelium—metabolic syndrome X	0.00257	0.0292	CbGeAlD
Asenapine—Blood disorder—Metformin—metabolic syndrome X	0.0024	0.0624	CcSEcCtD
Asenapine—HTR7—blood vessel—metabolic syndrome X	0.00237	0.0269	CbGeAlD
Asenapine—HRH2—cardiovascular system—metabolic syndrome X	0.00208	0.0236	CbGeAlD
Asenapine—UGT1A4—liver—metabolic syndrome X	0.00205	0.0233	CbGeAlD
Asenapine—HTR2A—artery—metabolic syndrome X	0.0019	0.0216	CbGeAlD
Asenapine—HTR2A—endothelium—metabolic syndrome X	0.0016	0.0182	CbGeAlD
Asenapine—HTR2A—blood vessel—metabolic syndrome X	0.00148	0.0168	CbGeAlD
Asenapine—Pain in extremity—Metformin—metabolic syndrome X	0.00146	0.0379	CcSEcCtD
Asenapine—HTR1B—cardiovascular system—metabolic syndrome X	0.00137	0.0156	CbGeAlD
Asenapine—HTR1D—cardiovascular system—metabolic syndrome X	0.00133	0.0151	CbGeAlD
Asenapine—Breast disorder—Metformin—metabolic syndrome X	0.00132	0.0342	CcSEcCtD
Asenapine—HTR1D—kidney—metabolic syndrome X	0.0013	0.0148	CbGeAlD
Asenapine—ADRB1—cardiovascular system—metabolic syndrome X	0.00129	0.0147	CbGeAlD
Asenapine—HRH2—liver—metabolic syndrome X	0.00129	0.0146	CbGeAlD
Asenapine—Amoxapine—HTR2C—metabolic syndrome X	0.00124	0.561	CrCbGaD
Asenapine—HTR2B—cardiovascular system—metabolic syndrome X	0.00124	0.014	CbGeAlD
Asenapine—Abdominal discomfort—Metformin—metabolic syndrome X	0.00121	0.0314	CcSEcCtD
Asenapine—Neutropenia—Metformin—metabolic syndrome X	0.00118	0.0306	CcSEcCtD
Asenapine—ADRB1—adipose tissue—metabolic syndrome X	0.00114	0.0129	CbGeAlD
Asenapine—HTR1A—cardiovascular system—metabolic syndrome X	0.00111	0.0126	CbGeAlD
Asenapine—HTR2B—adipose tissue—metabolic syndrome X	0.00109	0.0124	CbGeAlD
Asenapine—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00106	0.0276	CcSEcCtD
Asenapine—HTR7—cardiovascular system—metabolic syndrome X	0.00106	0.012	CbGeAlD
Asenapine—HTR7—kidney—metabolic syndrome X	0.00104	0.0118	CbGeAlD
Asenapine—ADRA1A—cardiovascular system—metabolic syndrome X	0.00102	0.0116	CbGeAlD
Asenapine—Oedema peripheral—Metformin—metabolic syndrome X	0.000992	0.0258	CcSEcCtD
Asenapine—Connective tissue disorder—Metformin—metabolic syndrome X	0.000989	0.0257	CcSEcCtD
Asenapine—Loxapine—HTR2C—metabolic syndrome X	0.000972	0.439	CrCbGaD
Asenapine—ADRA2C—kidney—metabolic syndrome X	0.000952	0.0108	CbGeAlD
Asenapine—Eye disorder—Metformin—metabolic syndrome X	0.000941	0.0245	CcSEcCtD
Asenapine—Cardiac disorder—Metformin—metabolic syndrome X	0.000934	0.0243	CcSEcCtD
Asenapine—Angiopathy—Metformin—metabolic syndrome X	0.000913	0.0238	CcSEcCtD
Asenapine—Immune system disorder—Metformin—metabolic syndrome X	0.000909	0.0237	CcSEcCtD
Asenapine—Mediastinal disorder—Metformin—metabolic syndrome X	0.000907	0.0236	CcSEcCtD
Asenapine—ADRA1A—adipose tissue—metabolic syndrome X	0.0009	0.0102	CbGeAlD
Asenapine—Malnutrition—Metformin—metabolic syndrome X	0.000876	0.0228	CcSEcCtD
Asenapine—Dysgeusia—Metformin—metabolic syndrome X	0.000858	0.0223	CcSEcCtD
Asenapine—ADRA2C—adipose tissue—metabolic syndrome X	0.000858	0.00974	CbGeAlD
Asenapine—Muscle spasms—Metformin—metabolic syndrome X	0.000843	0.0219	CcSEcCtD
Asenapine—Tremor—Metformin—metabolic syndrome X	0.000821	0.0214	CcSEcCtD
Asenapine—Malaise—Metformin—metabolic syndrome X	0.00079	0.0206	CcSEcCtD
Asenapine—Syncope—Metformin—metabolic syndrome X	0.000786	0.0204	CcSEcCtD
Asenapine—Loss of consciousness—Metformin—metabolic syndrome X	0.00077	0.02	CcSEcCtD
Asenapine—Hypertension—Metformin—metabolic syndrome X	0.000757	0.0197	CcSEcCtD
Asenapine—Shock—Metformin—metabolic syndrome X	0.000704	0.0183	CcSEcCtD
Asenapine—Nervous system disorder—Metformin—metabolic syndrome X	0.000701	0.0182	CcSEcCtD
Asenapine—Thrombocytopenia—Metformin—metabolic syndrome X	0.0007	0.0182	CcSEcCtD
Asenapine—HRH1—adipose tissue—metabolic syndrome X	0.000697	0.00791	CbGeAlD
Asenapine—ADRA2A—adipose tissue—metabolic syndrome X	0.000684	0.00777	CbGeAlD
Asenapine—Hypotension—Metformin—metabolic syndrome X	0.000668	0.0174	CcSEcCtD
Asenapine—HTR2A—cardiovascular system—metabolic syndrome X	0.00066	0.00749	CbGeAlD
Asenapine—HTR7—liver—metabolic syndrome X	0.000654	0.00743	CbGeAlD
Asenapine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000652	0.017	CcSEcCtD
Asenapine—HTR2A—kidney—metabolic syndrome X	0.000646	0.00733	CbGeAlD
Asenapine—Dyspnoea—Metformin—metabolic syndrome X	0.000638	0.0166	CcSEcCtD
Asenapine—Somnolence—Metformin—metabolic syndrome X	0.000636	0.0165	CcSEcCtD
Asenapine—ADRA1A—liver—metabolic syndrome X	0.000631	0.00716	CbGeAlD
Asenapine—Dyspepsia—Metformin—metabolic syndrome X	0.00063	0.0164	CcSEcCtD
Asenapine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000618	0.0161	CcSEcCtD
Asenapine—Fatigue—Metformin—metabolic syndrome X	0.000617	0.016	CcSEcCtD
Asenapine—Constipation—Metformin—metabolic syndrome X	0.000612	0.0159	CcSEcCtD
Asenapine—ADRA2C—liver—metabolic syndrome X	0.000602	0.00683	CbGeAlD
Asenapine—CYP3A4—kidney—metabolic syndrome X	0.000598	0.00678	CbGeAlD
Asenapine—CYP2D6—kidney—metabolic syndrome X	0.000588	0.00668	CbGeAlD
Asenapine—CYP1A2—liver—metabolic syndrome X	0.000522	0.00592	CbGeAlD
Asenapine—Asthenia—Metformin—metabolic syndrome X	0.000513	0.0133	CcSEcCtD
Asenapine—Dizziness—Metformin—metabolic syndrome X	0.000473	0.0123	CcSEcCtD
Asenapine—Vomiting—Metformin—metabolic syndrome X	0.000455	0.0118	CcSEcCtD
Asenapine—Rash—Metformin—metabolic syndrome X	0.000451	0.0117	CcSEcCtD
Asenapine—Dermatitis—Metformin—metabolic syndrome X	0.000451	0.0117	CcSEcCtD
Asenapine—Headache—Metformin—metabolic syndrome X	0.000448	0.0117	CcSEcCtD
Asenapine—Nausea—Metformin—metabolic syndrome X	0.000425	0.0111	CcSEcCtD
Asenapine—HTR2A—liver—metabolic syndrome X	0.000408	0.00463	CbGeAlD
Asenapine—CYP3A4—liver—metabolic syndrome X	0.000378	0.00429	CbGeAlD
Asenapine—CYP2D6—liver—metabolic syndrome X	0.000372	0.00422	CbGeAlD
Asenapine—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.09e-05	5.6e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	1.09e-05	5.59e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	1.09e-05	5.59e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	1.08e-05	5.57e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.08e-05	5.55e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.08e-05	5.55e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL6—metabolic syndrome X	1.08e-05	5.55e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL6—metabolic syndrome X	1.08e-05	5.54e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.08e-05	5.54e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.08e-05	5.53e-05	CbGpPWpGaD
Asenapine—UGT1A4—Metabolism—AKT1—metabolic syndrome X	1.08e-05	5.52e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	1.07e-05	5.51e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.07e-05	5.5e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.07e-05	5.5e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	1.07e-05	5.49e-05	CbGpPWpGaD
Asenapine—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.07e-05	5.48e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.06e-05	5.47e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.06e-05	5.44e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.06e-05	5.44e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	1.05e-05	5.39e-05	CbGpPWpGaD
Asenapine—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.05e-05	5.39e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.05e-05	5.37e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.05e-05	5.37e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.04e-05	5.35e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.04e-05	5.33e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.04e-05	5.32e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	1.03e-05	5.31e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.03e-05	5.29e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.03e-05	5.29e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—INS—metabolic syndrome X	1.02e-05	5.22e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.02e-05	5.22e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.02e-05	5.22e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.01e-05	5.2e-05	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.01e-05	5.19e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.01e-05	5.19e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1e-05	5.16e-05	CbGpPWpGaD
Asenapine—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1e-05	5.15e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	9.99e-06	5.13e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	9.99e-06	5.13e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	9.98e-06	5.12e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—AKT1—metabolic syndrome X	9.98e-06	5.12e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—AKT1—metabolic syndrome X	9.97e-06	5.12e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	9.96e-06	5.11e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	9.96e-06	5.11e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.94e-06	5.1e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	9.92e-06	5.09e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	9.92e-06	5.09e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—LIPC—metabolic syndrome X	9.92e-06	5.09e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GCK—metabolic syndrome X	9.92e-06	5.09e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	9.9e-06	5.08e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	9.89e-06	5.08e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	9.87e-06	5.07e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOC3—metabolic syndrome X	9.86e-06	5.06e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	9.84e-06	5.05e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	9.83e-06	5.05e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	9.76e-06	5.01e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	9.74e-06	5e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	9.71e-06	4.98e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	9.7e-06	4.98e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOB—metabolic syndrome X	9.7e-06	4.98e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	9.68e-06	4.97e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	9.68e-06	4.97e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	9.62e-06	4.94e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CETP—metabolic syndrome X	9.57e-06	4.91e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	9.56e-06	4.91e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	9.54e-06	4.9e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—INS—metabolic syndrome X	9.5e-06	4.88e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	9.49e-06	4.87e-05	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.46e-06	4.85e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	9.44e-06	4.85e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	9.43e-06	4.84e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—metabolic syndrome X	9.35e-06	4.8e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	9.35e-06	4.8e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	9.35e-06	4.8e-05	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	9.33e-06	4.79e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—INS—metabolic syndrome X	9.33e-06	4.79e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—ALB—metabolic syndrome X	9.33e-06	4.79e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	9.31e-06	4.78e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—LPL—metabolic syndrome X	9.26e-06	4.75e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	9.2e-06	4.72e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	9.19e-06	4.72e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	9.19e-06	4.71e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	9.18e-06	4.71e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	9.18e-06	4.71e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	9.16e-06	4.7e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	9.16e-06	4.7e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	9.11e-06	4.67e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	9.04e-06	4.64e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	9.03e-06	4.63e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	9.01e-06	4.62e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	8.92e-06	4.58e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	8.9e-06	4.57e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	8.88e-06	4.56e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	8.86e-06	4.54e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CD36—metabolic syndrome X	8.8e-06	4.51e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	8.73e-06	4.48e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	8.65e-06	4.44e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	8.65e-06	4.44e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—AKT1—metabolic syndrome X	8.63e-06	4.43e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	8.59e-06	4.41e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.59e-06	4.41e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	8.57e-06	4.4e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	8.51e-06	4.37e-05	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.5e-06	4.36e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	8.48e-06	4.35e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	8.48e-06	4.35e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	8.47e-06	4.35e-05	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	8.43e-06	4.32e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	8.41e-06	4.32e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.41e-06	4.32e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	8.37e-06	4.3e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	8.37e-06	4.3e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	8.33e-06	4.28e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—metabolic syndrome X	8.33e-06	4.28e-05	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.32e-06	4.27e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	8.29e-06	4.26e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	8.24e-06	4.23e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	8.23e-06	4.22e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOB—metabolic syndrome X	8.21e-06	4.22e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	8.2e-06	4.21e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	8.19e-06	4.2e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	8.18e-06	4.2e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	8.18e-06	4.2e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	8.16e-06	4.19e-05	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.13e-06	4.17e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	8.11e-06	4.16e-05	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	8.09e-06	4.15e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	8.03e-06	4.12e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	8.01e-06	4.11e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	7.99e-06	4.1e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	7.97e-06	4.09e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AGT—metabolic syndrome X	7.92e-06	4.06e-05	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	7.87e-06	4.04e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—LPL—metabolic syndrome X	7.84e-06	4.02e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.81e-06	4.01e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—metabolic syndrome X	7.76e-06	3.98e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	7.75e-06	3.98e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	7.74e-06	3.97e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	7.72e-06	3.96e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	7.71e-06	3.96e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	7.71e-06	3.96e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—AKT1—metabolic syndrome X	7.69e-06	3.94e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	7.67e-06	3.94e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	7.65e-06	3.93e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	7.55e-06	3.88e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	7.47e-06	3.83e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	7.47e-06	3.83e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	7.46e-06	3.83e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CD36—metabolic syndrome X	7.45e-06	3.82e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.39e-06	3.79e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.35e-06	3.77e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	7.3e-06	3.75e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	7.2e-06	3.7e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.15e-06	3.67e-05	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	7.14e-06	3.66e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	7.03e-06	3.61e-05	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.03e-06	3.61e-05	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	7.01e-06	3.6e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	6.93e-06	3.56e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	6.92e-06	3.55e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	6.9e-06	3.54e-05	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.88e-06	3.53e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	6.77e-06	3.48e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	6.76e-06	3.47e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AGT—metabolic syndrome X	6.71e-06	3.44e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—INS—metabolic syndrome X	6.63e-06	3.4e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—metabolic syndrome X	6.57e-06	3.37e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	6.56e-06	3.37e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	6.5e-06	3.34e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	6.5e-06	3.34e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	6.49e-06	3.33e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	6.42e-06	3.29e-05	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.39e-06	3.28e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—metabolic syndrome X	6.39e-06	3.28e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—metabolic syndrome X	6.38e-06	3.28e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.38e-06	3.27e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	6.37e-06	3.27e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	6.34e-06	3.25e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOB—metabolic syndrome X	6.34e-06	3.25e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	6.29e-06	3.23e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.28e-06	3.22e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.25e-06	3.21e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.24e-06	3.2e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	6.21e-06	3.19e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	6.17e-06	3.16e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—metabolic syndrome X	6.11e-06	3.14e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—metabolic syndrome X	6.08e-06	3.12e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.07e-06	3.12e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—LPL—metabolic syndrome X	6.05e-06	3.11e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	5.89e-06	3.02e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	5.89e-06	3.02e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	5.85e-06	3e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	5.83e-06	2.99e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	5.81e-06	2.98e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.81e-06	2.98e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CD36—metabolic syndrome X	5.75e-06	2.95e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	5.73e-06	2.94e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	5.73e-06	2.94e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	5.64e-06	2.89e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—INS—metabolic syndrome X	5.62e-06	2.88e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	5.51e-06	2.83e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—metabolic syndrome X	5.5e-06	2.82e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—metabolic syndrome X	5.43e-06	2.78e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.42e-06	2.78e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	5.41e-06	2.78e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	5.38e-06	2.76e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	5.35e-06	2.74e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	5.32e-06	2.73e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.31e-06	2.72e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AGT—metabolic syndrome X	5.18e-06	2.66e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—metabolic syndrome X	5.15e-06	2.64e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	5.07e-06	2.6e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.07e-06	2.6e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—AKT1—metabolic syndrome X	5.05e-06	2.59e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.02e-06	2.57e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	5.01e-06	2.57e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	4.94e-06	2.54e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.93e-06	2.53e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	4.93e-06	2.53e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	4.9e-06	2.51e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	4.84e-06	2.48e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	4.73e-06	2.43e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	4.71e-06	2.41e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	4.58e-06	2.35e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	4.56e-06	2.34e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	4.52e-06	2.32e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	4.5e-06	2.31e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	4.46e-06	2.29e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	4.42e-06	2.27e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	4.36e-06	2.24e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	4.34e-06	2.23e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—INS—metabolic syndrome X	4.33e-06	2.22e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	4.22e-06	2.17e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	4.15e-06	2.13e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.1e-06	2.1e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.09e-06	2.1e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	4.08e-06	2.09e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4e-06	2.05e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.97e-06	2.04e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	3.83e-06	1.97e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.8e-06	1.95e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	3.77e-06	1.93e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	3.76e-06	1.93e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	3.72e-06	1.91e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.69e-06	1.89e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.48e-06	1.78e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	3.43e-06	1.76e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.67e-06	1.37e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.26e-06	1.16e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.75e-06	8.97e-06	CbGpPWpGaD
